You are using an older browser version. Please use a supported version for the best MSN experience.

'We are in it for the long run,' says Odyssey Acquisition on BenevolentAI merger

Jean Raby, co-CEO of Odyssey Acquisition, discusses the company's merger with BenevolentAI, the clinical stage AI drug discovery company.
image beaconimage beaconimage beacon